$2.41T
Total marketcap
$74.08B
Total volume
BTC 50.81%     ETH 14.95%
Dominance

Creades AB 0QI9.L Stock

68 SEK {{ price }} 0.378634% {{change_pct}}%
Exchange
LSE
Market Cap
9.29M SEK
LOW - HIGH [24H]
0.0000 - 0.0000 SEK
VOLUME [24H]
2.55K SEK
{{ volume }}
P/E Ratio
0.11
Earnings per share
5.8 SEK

Creades AB Price Chart

Creades AB 0QI9.L Financial and Trading Overview

Creades AB stock price 68 SEK
Previous Close 77.94 SEK
Open 0 SEK
Bid 0 SEK x 0
Ask 0 SEK x 0
Day's Range 0 - 0 SEK
52 Week Range 0 - 99.45 SEK
Volume 5.52K SEK
Avg. Volume 4.83K SEK
Market Cap 10.76M SEK
Beta (5Y Monthly) 1.044444
PE Ratio (TTM) 0.13593021
EPS (TTM) 5.8 SEK
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

0QI9.L Valuation Measures

Enterprise Value 10.05B SEK
Trailing P/E 0.13593021
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) -0.00766779
Price/Book (mrq) 1.1496644
Enterprise Value/Revenue -7.163
Enterprise Value/EBITDA -7.694

Trading Information

Creades AB Stock Price History

Beta (5Y Monthly) 1.044444
52-Week Change -0.063%
S&P500 52-Week Change 20.43%
52 Week High 99.45 SEK
52 Week Low 0 SEK
50-Day Moving Average 83.47 SEK
200-Day Moving Average 80.65 SEK

0QI9.L Share Statistics

Avg. Volume (3 month) 4.83K SEK
Avg. Daily Volume (10-Days) 4.17K SEK
Shares Outstanding 12.47M
Float 53.35M
Short Ratio N/A
% Held by Insiders 47.16%
% Held by Institutions 15.29%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.4
Trailing Annual Dividend Yield 1.79%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor 10:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 93.08%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -7.89%
Return on Equity (ttm) -12.80%

Income Statement

Revenue (ttm) -1403000064 SEK
Revenue Per Share (ttm) -10.334 SEK
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) -4203000000 SEK
EBITDA -1306249984 SEK
Net Income Avi to Common (ttm) -1286000000 SEK
Diluted EPS (ttm) 5.795
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 534M SEK
Total Cash Per Share (mrq) 3.93 SEK
Total Debt (mrq) 3M SEK
Total Debt/Equity (mrq) 0.03 SEK
Current Ratio (mrq) 11.922
Book Value Per Share (mrq) 68.517

Cash Flow Statement

Operating Cash Flow (ttm) 129M SEK
Levered Free Cash Flow (ttm) -933249984 SEK

Profile of Creades AB

Country United Kingdom
State N/A
City Stockholm
Address Ingmar Bergmans gata 4
ZIP 10216
Phone 46 8 41 20 11 00
Website https://www.creades.se
Industry
Sector(s)
Full Time Employees 7

Creades AB is a private equity and venture capital investment firm specializing in seed/startup, early, mid & late venture, emerging growth, middle market, growth capital and buyout investments. The firm typically invests in small and medium-sized public and private companies. It focuses on Swedish companies. The firm seeks to invest between SEK100 ($15.51 million) and SEK300 million ($46.53 million). The firm prefers to take a majority stake and seat on the board of directors of its portfolio companies. The firm uses personal and balance sheet capital for making investments. Creades AB was founded in 2011 and is based in Stockholm, Sweden.

Q&A For Creades AB Stock

What is a current 0QI9.L stock price?

Creades AB 0QI9.L stock price today per share is 68 SEK.

How to purchase Creades AB stock?

You can buy 0QI9.L shares on the LSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Creades AB?

The stock symbol or ticker of Creades AB is 0QI9.L.

How many shares does Creades AB have in circulation?

The max supply of Creades AB shares is 136.57K.

What is Creades AB Price to Earnings Ratio (PE Ratio)?

Creades AB PE Ratio is 0.11734254 now.

What was Creades AB earnings per share over the trailing 12 months (TTM)?

Creades AB EPS is 5.8 SEK over the trailing 12 months.